GUIDED THERAPEUTICS INC Note Agreements
34 Contracts & Agreements
- Promissory Note, dated July 23, 2024, in the amount of $50,000 (Filed With SEC on November 14, 2024)
- Form of Promissory Note issued to Directors (Filed With SEC on November 14, 2024)
- $62,100 Promissory Note Dated July 22, 2024 with 1800 Diagonal Lending (Filed With SEC on August 14, 2024)
- $100,050 Promissory Note Dated June 11, 2024 with 1800 Diagonal Lending (Filed With SEC on August 14, 2024)
- Form of Amended Promissory Note to Mark Faupel (Filed With SEC on May 15, 2023)
- Form of Amended Promissory Note to Gene Cartwright (Filed With SEC on May 15, 2023)
- Promissory Note, dated December 31, 2021, by and between Guided Therapeutics, Inc. and William Wells (Filed With SEC on March 30, 2022)
- Note Payable Agreement with Mark Faupel, dated February 19, 2021 (Filed With SEC on April 7, 2021)
- Note Payable Agreement with Gene Cartwright, dated February 19, 2021 (Filed With SEC on April 7, 2021)
- Convertible Promissory Note with Auctus, dated March 31, 2020 (Filed With SEC on April 7, 2021)
- Promissory Note, dated as of January 15, 2020, by and between Guided Therapeutics, Inc. and IRTH Communications, LLC (Filed With SEC on April 20, 2020)
- Promissory Note, dated as of February 15, 2019, by and between Guided Therapeutics, Inc. and Mr. Gould (Filed With SEC on April 20, 2020)
- Promissory Note, dated as of September 19, 2018, by and between Guided Therapeutics, Inc. and Mr. Gould (Filed With SEC on April 20, 2020)
- Promissory Note, dated as of August 22, 2018, by and between Guided Therapeutics, Inc. and Mr. Case (Filed With SEC on April 20, 2020)
- Senior Secured Convertible Note, dated December 17, 2019, by and between Guided Therapeutics, Inc. and Auctus Fund, LLC (Filed With SEC on April 20, 2020)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 13, 2017)
- ADARBAYS, LLC COLLATERALIZEDSECURED PROMISSORY NOTE (Filed With SEC on May 24, 2017)
- GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE (Filed With SEC on May 24, 2017)
- GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 (Filed With SEC on May 24, 2017)
- GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 BACKEND NOTE (Filed With SEC on May 24, 2017)
- GUIDEDTHERAPEUTICS, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUEMAY 17, 2018 (Filed With SEC on May 24, 2017)
- CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 17, 2017)
- 10% OID Convertible Promissory Note (Filed With SEC on December 30, 2016)
- FORM OF NOTE (Filed With SEC on December 7, 2016)
- 17%Senior SECURED Convertible NOTE (Filed With SEC on February 16, 2016)
- SENIORCONVERTIBLE NOTE (Filed With SEC on June 30, 2015)
- Note Purchase Agreement, dated September 10, 2014, by and between the Company and Tonaquint (Filed With SEC on September 10, 2014)
- Secured Promissory Note, dated September 10, 2014 (Filed With SEC on September 10, 2014)
- Form of Senior Convertible Note (Filed With SEC on April 24, 2014)
- Amended Promissory Note (Maloof), April 10, 2008 (Filed With SEC on October 1, 2008)
- Promissory note and Security Agreement dated as of October 26, 2005, by and among SpectRx, Inc. and the noteholders (Filed With SEC on November 1, 2005)
- Promissory note and Security Agreement dated as of October 20, 2005, by and among SpectRx, Inc. and the noteholder (Filed With SEC on October 26, 2005)
- Promissory note and Security Agreement dated as of October 5, 2005, by and among SpectRx, Inc. and the noteholders (Filed With SEC on October 12, 2005)
- Promissory note and Security Agreement dated as of September 6, 2005, by and among SpectRx, Inc. and the officers (Filed With SEC on September 12, 2005)
